2d955155 686d 40cd 898e Df7d760247a5 740 1
Lamotrigine Tablet
Product Images NDC 50090-3914
7 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 50090-3914). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
2d955155 686d 40cd 898e Df7d760247a5 789 2
An illustration showing four different Lamotrigine tablets by strength and shape: a white 25 mg oval tablet engraved with 'U 111'; a white 100 mg triangular tablet engraved with 'U 112'; a white 150 mg triangular tablet engraved with 'U 113'; and a light blue 200 mg triangular tablet engraved with 'U 114'.*
2d955155 686d 40cd 898e Df7d760247a5 789 3
Ad7af627 Ea4b 4a78 A71e Db1255416d1e 01
Chemical structure of lamotrigine depicting the molecular framework, including a chlorinated benzene ring and a triazine ring with amino groups, consistent with its chemical makeup.*
Ad7af627 Ea4b 4a78 A71e Db1255416d1e 02
A Kaplan-Meier failure probability plot comparing two groups over time in weeks. The vertical axis shows failure probability percentage, and the horizontal axis shows weeks up to 100. Two lines represent Placebo and Lamotrigine groups, with censored data points marked. The chart illustrates differences in failure probability between the two groups over the study period.*
Ad7af627 Ea4b 4a78 A71e Db1255416d1e 03
A Kaplan-Meier failure probability plot comparing Lamotrigine and placebo over approximately 80 weeks. The vertical axis shows failure probability as a percentage, and the horizontal axis shows time in weeks. Curves indicate a lower failure probability for Lamotrigine compared to placebo with censored data points marked.*
Label Image (Lbl500903914)
Lamotrigine 200 mg oral tablets label from A-S Medication Solutions, showing the product name, strength, and quantity of 60 tablets. The label includes storage instructions to keep between 68 to 77 degrees Fahrenheit in a dry place and notes that each scored tablet contains 200 mg of lamotrigine USP. The labeler information and NDC 50090-3914-0 are visible.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
